T2 Biosystems Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 151
Employees
  • Stock Symbol
  • TTOO
Stock Symbol
  • Share Price
  • $1.33
  • (As of Thursday Closing)

T2 Biosystems General Information

Description

T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
  • 91 Hartwell Avenue
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000

T2 Biosystems Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

T2 Biosystems Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.33 $1.30 $0.23 - $3.15 $197M 148M 6.37M -$0.87

T2 Biosystems Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 162,273 84,963 115,415 137,205
Revenue 9,843 8,335 10,500 4,666
EBITDA (43,645) (48,016) (42,022) (50,581)
Net Income (53,846) (59,006) (51,153) (62,428)
Total Assets 53,714 28,486 64,309 54,861
Total Debt 46,934 46,758 43,133 42,681
Public Fundamental Data provided by Morningstar, Inc. disclaimer

T2 Biosystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore T2 Biosystems‘s full profile, request access.

Request a free trial

T2 Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore T2 Biosystems‘s full profile, request access.

Request a free trial

T2 Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is T2 Magn
Diagnostic Equipment
Lexington, MA
151 As of 2019
00000
00000000000 00000

0000000

u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
0000000000 000000000
Carlsbad, CA
000 As of 0000
0000
000000000 0000

00000000

lor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magn
0000000000 000000000
Mechelen, Belgium
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

T2 Biosystems Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GenMark Diagnostics Corporation Carlsbad, CA 000 0000 000000000 0000
000000000 Formerly VC-backed Mechelen, Belgium 000 00000 000000000 00000
000000000000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
0000 00000000000 Corporate Backed or Acquired Nehren, Germany 000000&0
0000-00 Formerly VC-backed Barcelona, Spain 000.00 000000&0 000.00
You’re viewing 5 of 25 competitors. Get the full list »

T2 Biosystems Executive Team (19)

Name Title Board Seat Contact Info
John Sperzel III Chief Executive Officer & Board Member
John Sprague Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Tom Lowery Ph.D Chief Scientific Officer
Frederic Sweeney Senior Director, Business Development
Lee Josephson Ph.D Co-Founder
You’re viewing 5 of 19 executive team members. Get the full list »

T2 Biosystems Board Members (21)

Name Representing Role Since
Adrian Jones Self Board Member 000 0000
David Elsbree T2 Biosystems Board Member 000 0000
John Cumming T2 Biosystems Board Member 000 0000
John McDonough T2 Biosystems Chairman & Board Member 000 0000
John Sperzel III T2 Biosystems Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

T2 Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

T2 Biosystems Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore T2 Biosystems‘s full profile, request access.

Request a free trial